Vitekta

Country: New Zealand

Lingwa: Ingliż

Sors: Medsafe (Medicines Safety Authority)

Ingredjent attiv:

Elvitegravir 85mg;  ;  ;  ;  

Disponibbli minn:

Gilead Sciences (NZ)

INN (Isem Internazzjonali):

Elvitegravir 85 mg

Dożaġġ:

85 mg

Għamla farmaċewtika:

Film coated tablet

Kompożizzjoni:

Active: Elvitegravir 85mg         Excipient: Croscarmellose sodium Hyprolose Lactose monohydrate Magnesium stearate Microcrystalline cellulose Opadry green 85F91203 Sodium laurilsulfate

Tip ta 'preskrizzjoni:

Prescription

Manifatturat minn:

Gilead Sciences Inc

Indikazzjonijiet terapewtiċi:

Indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults and adolescents when co-administered with a ritonavir-boosted protease inhibitor and other antiretroviral therapy.

Sommarju tal-prodott:

Package - Contents - Shelf Life: Bottle, plastic, HDPE with child resistant PE cap - 30 tablets - 24 months from date of manufacture stored at or below 25°C

Data ta 'l-awtorizzazzjoni:

2013-11-04